[go: up one dir, main page]

Garnier et al., 2015 - Google Patents

PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development

Garnier et al., 2015

View PDF @Full View
Document ID
4872720614737470668
Author
Garnier V
Traboulsi W
Salomon A
Brouillet S
Fournier T
Winkler C
Desvergne B
Hoffmann P
Zhou Q
Congiu C
Onnis V
Benharouga M
Feige J
Alfaidy N
Publication year
Publication venue
American Journal of Physiology-Endocrinology and Metabolism

External Links

Snippet

PPARγ-deficient mice die at E9. 5 due to placental abnormalities. The mechanism by which this occurs is unknown. We demonstrated that the new endocrine factor EG-VEGF controls the same processes as those described for PPARγ, suggesting potential regulation of EG …
Continue reading at journals.physiology.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Similar Documents

Publication Publication Date Title
Garnier et al. PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development
Li et al. Human placenta‐derived mesenchymal stem cells inhibit apoptosis of granulosa cells induced by IRE1α pathway in autoimmune POF mice
Li et al. WNT4 acts downstream of BMP2 and functions via β-catenin signaling pathway to regulate human endometrial stromal cell differentiation
Otsuka et al. Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice
Stilley et al. Signaling through FSH receptors on human umbilical vein endothelial cells promotes angiogenesis
Mukherjee et al. Oxidative stress-induced impairment of trophoblast function causes preeclampsia through the unfolded protein response pathway
Toro et al. Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation
Hombrebueno et al. Uncoupled turnover disrupts mitochondrial quality control in diabetic retinopathy
Zhou et al. The proprotein convertase furin is required for trophoblast syncytialization
Chauvigné et al. Toward developing recombinant gonadotropin-based hormone therapies for increasing fertility in the flatfish Senegalese sole
Yu et al. Placensin is a glucogenic hormone secreted by human placenta
Chen et al. Expression of GRIM-19 in missed abortion and possible pathogenesis
Denison et al. Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta
Ouhilal et al. Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance
Chen et al. Human β-defensin-3 reduces excessive autophagy in intestinal epithelial cells and in experimental necrotizing enterocolitis
Boyer et al. Synchronized proinsulin trafficking reveals delayed Golgi export accompanies β-cell secretory dysfunction in rodent models of hyperglycemia
Moindjie et al. Preimplantation factor is an anti-apoptotic effector in human trophoblasts involving p53 signaling pathway
Ziegelmüller et al. Expression of thyroid hormone receptors in villous trophoblasts and decidual tissue at protein and mRNA levels is downregulated in spontaneous and recurrent miscarriages
Kannan et al. Maternal high-fat diet during pregnancy with concurrent phthalate exposure leads to abnormal placentation
Feng et al. The role of progesterone and a novel progesterone receptor, progesterone receptor membrane component 1, in the inflammatory response of fetal membranes to Ureaplasma parvum infection
Gosemann et al. Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia
Kadmiel et al. Loss of receptor activity-modifying protein 2 in mice causes placental dysfunction and alters PTH1R regulation
Laguë et al. Decidual PTEN expression is required for trophoblast invasion in the mouse
Dong et al. Calcitonin gene-related peptide (CALCA) is a proangiogenic growth factor in the human placental development
Hung et al. Absence of Slc39a14/Zip14 in mouse pancreatic beta cells results in hyperinsulinemia